Cannabis may ease ‘chemo brain,’ improve sleep for cancer patients, study shows

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

A study led by researchers at the University of Colorado Boulder, published in the journal Exploration of Medicine, is among the first to assess how cannabis bought over the counter at dispensaries—rather than government-supplied or synthetic varieties—impacts cancer symptoms or chemotherapy side effects. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

A meta-analysis of 25 studies—totaling over 5,000 participants—focused on a question that has been troubling patients, physicians, and regulators: Does treatment with CAR T-cell therapy contribute to the development of secondary cancers?

Can you spare 10 minutes to complete a survey?

Your feedback is really important—you're helping us shape our coverage priorities and services to better serve you, our readers.

Login